Author

Anne‐Sophie Mehdorn

University Hospital Schleswig-HolsteinORCID 0000-0003-4415-8371Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anna Maxi WandmacheriD· 1 shared Anne Schmidt· 1 shared Annika BräueriD· 1 shared Ashini Kumar HidamiD· 1 shared Benjamin Heckelmann· 1 shared Caj Stach· 1 shared Charlotte KayseriD· 1 shared Christoph RöckeniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna Maxi WandmacherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 19, 2026

L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the complex tumor stroma

Anna Maxi Wandmacher, Annika Bräuer, Charlotte Kayser…·Susanne Sebens

This study shows L1CAMxCD3 bispecific antibodies effectively target PDAC cells in immunosuppressive models, inducing apoptosis and T cell effector molecule release.

DOI 10.64898/2026.08.10.743835

humanbulk RNA-seq

𝕏 PostBluesky